Secondary outcomes were markers of inflammation ( serum C-reactive protein -LSB- CRP -RSB- , interleukin -LSB- IL -RSB- -@ , IL-@ , and tumor necrosis factor -LSB- TNF -RSB- ) and prevalent and incident cancer and cardiovascular disease .